title: Ultrapure dialysate reduces dose of recombinant human erythropoietin.
authors.forename: H
authors.initials: H
authors.lastname: Schiffl
authors.forename: S M
authors.initials: SM
authors.lastname: Lang
authors.forename: A
authors.initials: A
authors.lastname: Bergner
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D018592:Cross-Over Studies; D015314:Dialysis Solutions / Q000008:administration & dosage* / Q000592:standards*; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000592:standards
chemical_list: D015314:Dialysis Solutions; D011994:Recombinant Proteins; D004921:Erythropoietin